Menu Search
Equities

Laekna Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
2105:HKG

Laekna Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)12.82
  • Today's Change0.36 / 2.89%
  • Shares traded1.17m
  • 1 Year change+41.66%
  • Beta--
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow in CNYView more

In 2024, Laekna Inc increased its cash reserves by 43.90%, or 193.51m. Cash Flow from Financing totalled 258.08m or -- of revenues. In addition the company used 278.30m for operations while cash from investing totalled 208.19m.
Cash flow per share-0.7244
Price/Cash flow per share--
Book value per share1.98
Tangible book value per share1.63
More ▼

Balance sheet in CNYView more

Laekna Inc appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 636.42m.
Current ratio3.92
Quick ratio--
Total debt/total equity0.1605
Total debt/total capital0.1383
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.